The AI ​​revolution pervading big pharma took a huge financial step forward on Wednesday when VCs and large drug makers came together to acquire a cloud-focused company. Led by the Carlyle Group, investors will provide $ 430 million for a controlling interest in Saama, a patient data collection company

Source link

Leave a Reply